Myriad Genetics (MYGN) Income from Continuing Operations (2009 - 2026)
Myriad Genetics (MYGN) posted quarterly Income from Continuing Operations of 34100000.0 for Q1 2026, down 34000.0% year-over-year from N/an in Q1 2025, and down 331.65% quarter-over-quarter from 7900000.0 in Q4 2025.
Myriad Genetics (MYGN) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Myriad Genetics (MYGN) has reported Income from Continuing Operations for 18 consecutive years, with 34100000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 34000.0% year-over-year to 34100000.0; the TTM figure through Mar 2026 stood at 399900000.0 (down 294.38% YoY), while the FY2025 annual figure was 365900000.0, down 187.43% from the prior year.
- Income from Continuing Operations retreated to 34100000.0 in Q1 2026 per MYGN's latest filing, from 7900000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 100000.0 in Q1 2025 and bottomed at 330500000.0 in Q2 2025.
- Historically, Income from Continuing Operations has averaged 53094117.65 across 5 years, with a median of 34100000.0 in 2026.
- Annual changes were most pronounced in 2025 — Income from Continuing Operations surged 99.62% — and 2026, when it plunged 34000.0%.
- Myriad Genetics' Income from Continuing Operations stood at 42300000.0 in 2022, then gained by 26.24% to 31200000.0 in 2023, then plunged by 36.22% to 42500000.0 in 2024, then jumped by 81.41% to 7900000.0 in 2025, then slumped by 331.65% to 34100000.0 in 2026.
- Business Quant data shows MYGN's Income from Continuing Operations at 34100000.0 in Q1 2026, 7900000.0 in Q4 2025, and 27400000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 338.41 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -85.11 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 324.00 Mn |
| 10 | Myriad Genetics | 297.97 Mn | 173.57 Mn | 137.60 Mn | -34.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.10 Mn |
| Dec 31, 2025 | -7.90 Mn |
| Sep 30, 2025 | -27.40 Mn |
| Jun 30, 2025 | -330.50 Mn |
| Mar 31, 2025 | -100,000.00 |
| Dec 31, 2024 | -42.50 Mn |
| Sep 30, 2024 | -22.10 Mn |
| Jun 30, 2024 | -36.70 Mn |
| Mar 31, 2024 | -26.00 Mn |
| Dec 31, 2023 | -31.20 Mn |
| Sep 30, 2023 | -61.30 Mn |
| Jun 30, 2023 | -116.10 Mn |
| Mar 31, 2023 | -54.70 Mn |
| Dec 31, 2022 | -42.30 Mn |
| Sep 30, 2022 | -35.10 Mn |
| Jun 30, 2022 | -14.10 Mn |
| Mar 31, 2022 | -20.50 Mn |
| Dec 31, 2021 | -7.60 Mn |
| Sep 30, 2021 | 24.60 Mn |
| Jun 30, 2021 | -4.70 Mn |